secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001493152-25-027746
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience reports fiscal Q1 2026 revenue up 27% to $707K, net loss narrows to $464K
--------------------------------------------------------------------------------

- Net product sales $707K for Q1 ended Oct 31, 2025, up 27% from $555K YoY.
- Net loss $464K vs $689K year ago; net loss per share ($0.00) vs ($0.01).
- Adjusted net loss (excl. share-based comp) was $430K vs $632K.
- PURE Control now treating leafy greens for commercial sale; traction in transportation with SDC-powered sanitation.
- Working with distribution partners in beverage and dairy to roll out membrane treatment solutions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315225027746/0001493152-25-027746-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315225027746/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-027746

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer